PLASMAPP CO., LTD. Plasmapp Co., Ltd. Share Price
Equities
A405000
KR7405000001
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,660 KRW | +1.33% |
|
+8.79% | -35.12% |
| 04-21 | Plasmapp Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding | CI |
| 2023 | AdaptivEndo and Plasmapp Collaborate to Develop Sterilization Techniques for Flexible Endoscopy | CI |
| Sales 2022 | 13.31B 9.71M 765M | Sales 2023 | 12.92B 9.43M 743M | Capitalization | 79.58B 58.1M 4.58B |
|---|---|---|---|---|---|
| Net income 2022 | -17.68B -12.91M -1.02B | Net income 2023 | -18.79B -13.72M -1.08B | EV / Sales 2022 | 8.67 x |
| Net Debt 2022 | 14.36B 10.48M 826M | Net Debt 2023 | 11.78B 8.6M 677M | EV / Sales 2023 | 7.07 x |
| P/E ratio 2022 |
-5.21
x | P/E ratio 2023 |
-4.1
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.58% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.33% | ||
| 1 week | +8.79% | ||
| Current month | +11.53% | ||
| 1 month | +9.24% | ||
| 3 months | -14.61% | ||
| 6 months | -38.99% | ||
| Current year | -35.12% |
1 week
2 375.00
2 755.00
1 month
2 355.002 755.00
Current year
2 300.004 360.00
1 year
2 300.007 250.00
3 years
2 300.009 150.00
5 years
2 300.009 150.00
10 years
2 300.009 150.00
| Managers | Title | Age | Since |
|---|---|---|---|
Youbong Lim
CEO | Chief Executive Officer | - | 31/12/14 |
Hong Sun Lee
DFI | Director of Finance/CFO | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/05/24 | 2,660 | +1.33% | 115 147 |
| 28/05/24 | 2,625 | +5.00% | 263,938 |
| 27/05/24 | 2,500 | +0.40% | 63,977 |
| 24/05/24 | 2,490 | +2.05% | 58,699 |
| 23/05/24 | 2,440 | +1.88% | 64,422 |
End-of-day quote Korea S.E., May 28, 2024
More quotes
Plasmapp Co Ltd is a Korea-based company mainly engaged in the provision of medical solutions. The Company is engaged in the provision of low temperature plasma sterilization solutions, implant regeneration and activation solutions. The Company is also engaged in the manufacture and sale of medical devices. The Company's products include sterilizers, sterile consumables, regenerative activators, consumables, accessories and others.
Calendar
11/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -35.12% | 39.09M | |
| +75.71% | 12.56B | |
| -23.94% | 7.47B | |
| +6.99% | 6.75B | |
| +11.63% | 5.5B | |
| -16.58% | 4.94B | |
| +29.47% | 4.66B | |
| -25.47% | 3.75B | |
| -23.07% | 2.92B | |
| -2.23% | 1.98B |
- Stock Market
- Equities
- A405000 Stock
